Sandra Garcês

856 total citations
16 papers, 567 citations indexed

About

Sandra Garcês is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Sandra Garcês has authored 16 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Genetics. Recurrent topics in Sandra Garcês's work include Biosimilars and Bioanalytical Methods (7 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Sandra Garcês is often cited by papers focused on Biosimilars and Bioanalytical Methods (7 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Sandra Garcês collaborates with scholars based in Portugal, United States and Netherlands. Sandra Garcês's co-authors include Jocelyne Demengeot, Elizabeth Benito‐Garcia, Lucien A. Aarden, Marília Antunes, Matthew Baker, Maureen R. Deehan, Arno Kromminga, Daniel Kramer, Talia M. Muram and Susan Ball and has published in prestigious journals such as Neurology, Annals of the Rheumatic Diseases and Journal of Investigative Dermatology.

In The Last Decade

Sandra Garcês

16 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Garcês Portugal	8	302	230	177	89	77	16	567
Kim Murphy Australia	8	195 0.6×	149 0.6×	86 0.5×	52 0.6×	73 0.9×	12	411
Ceara AE Walsh Ireland	10	198 0.7×	394 1.7×	38 0.2×	85 1.0×	158 2.1×	11	717
M. Schiff United States	5	180 0.6×	422 1.8×	66 0.4×	116 1.3×	201 2.6×	10	656
Marina Stanislav Russia	9	192 0.6×	430 1.9×	83 0.5×	126 1.4×	179 2.3×	20	601
Vira Tseluyko Ukraine	8	451 1.5×	398 1.7×	65 0.4×	34 0.4×	121 1.6×	33	717
Magdalena Herczyńska Poland	11	124 0.4×	288 1.3×	42 0.2×	111 1.2×	127 1.6×	13	473
Takaharu Ikeda Japan	13	155 0.5×	315 1.4×	41 0.2×	43 0.5×	24 0.3×	51	500
Irene Smolik Canada	14	140 0.5×	495 2.2×	202 1.1×	57 0.6×	78 1.0×	28	692
Jeffrey Box United States	3	137 0.5×	336 1.5×	95 0.5×	112 1.3×	177 2.3×	5	445
Emma Vernon United States	5	176 0.6×	503 2.2×	59 0.3×	105 1.2×	256 3.3×	9	738

Countries citing papers authored by Sandra Garcês

Since Specialization

Citations

This map shows the geographic impact of Sandra Garcês's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Garcês with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Garcês more than expected).

Fields of papers citing papers by Sandra Garcês

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Garcês. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Garcês. The network helps show where Sandra Garcês may publish in the future.

Co-authorship network of co-authors of Sandra Garcês

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Garcês. A scholar is included among the top collaborators of Sandra Garcês based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Garcês. Sandra Garcês is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Rich, Nicole E., Gloria Figueroa, Sandra Garcês, et al.. (2025). Racial and ethnic differences in social determinants of health among patients with HCC. Hepatology Communications. 9(7). 4 indexed citations

Martinez, James M., Nada Hindiyeh, Greg Anglin, et al.. (2020). Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine. Cephalalgia. 40(9). 978–989. 9 indexed citations

Martinez, James M., Nada Hindiyeh, Greg Anglin, et al.. (2019). Immunogenicity Assessment from Phase 3 Galcanezumab Trials in Patients with Episodic or Chronic Migraine (P1.10-017). Neurology. 92(15_supplement). 2 indexed citations

Marzo‐Ortega, Helena, Eduardo Mysler, Tetsuya Tomita, et al.. (2019). FRI0400 LONG-TERM SAFETY OF IXEKIZUMAB IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS/ANKYLOSING SPONDYLITIS: AN INTEGRATED ANALYSIS OF COAST-V AND COAST-W. Annals of the Rheumatic Diseases. 78. 885–886. 4 indexed citations

Reich, Kristian, Kimberley Jackson, Susan Ball, et al.. (2018). Ixekizumab Pharmacokinetics, Anti-Drug Antibodies, and Efficacy through 60 Weeks of Treatment of Moderate to Severe Plaque Psoriasis. Journal of Investigative Dermatology. 138(10). 2168–2173. 39 indexed citations

Goupille, Philippe, Euthalia Roussou, Gerd R Burmester, et al.. (2018). SAT0348 Safety of ixekizumab in patients with psoriatic arthritis: results from a pooled analysis of three clinical trials. Annals of the Rheumatic Diseases. 77. 1039–1040. 5 indexed citations

Garcês, Sandra & Jocelyne Demengeot. (2017). The Immunogenicity of Biologic Therapies. Current problems in dermatology. 53. 37–48. 54 indexed citations

Deehan, Maureen R., et al.. (2015). Managing unwanted immunogenicity of biologicals. Autoimmunity Reviews. 14(7). 569–574. 48 indexed citations

Garcês, Sandra, et al.. (2013). A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies. Annals of the Rheumatic Diseases. 73(6). 1138–1143. 68 indexed citations

10.

Garcês, Sandra, et al.. (2013). FRI0188 The impact of immunogenicity on drug safety profile. Annals of the Rheumatic Diseases. 72. A436–A436. 1 indexed citations

11.

Garcês, Sandra, et al.. (2012). FRI0092 New algorithm to approach ra patients receiving biologic therapies: Introducing immunogenicity assessment in the eular guidelines. Annals of the Rheumatic Diseases. 71. 340–340. 1 indexed citations

12.

Garcês, Sandra, Jocelyne Demengeot, & Elizabeth Benito‐Garcia. (2012). The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis. Annals of the Rheumatic Diseases. 72(12). 1947–1955. 312 indexed citations

13.

Garcês, Sandra, et al.. (2012). AB1297 Bridging ELISA as a secreening assay to monitor immunogenicity in routine clinical practice. Annals of the Rheumatic Diseases. 71. 711–711. 1 indexed citations

14.

Garcês, Sandra, Jocelyne Demengeot, & Elizabeth Benito‐Garcia. (2012). SAT0479 Clinical impact of immunogenicity of infliximab, adalimumab and etanercept: A systematic review of the literature with a meta-analysis. Annals of the Rheumatic Diseases. 71. 634–635. 7 indexed citations

15.

Chamorro, C., et al.. (2009). Modulación hormonal del donante de órganos. Utilidad de los esteroides. Medicina Intensiva. 33(5). 251–255. 2 indexed citations

16.

Garcês, Sandra, et al.. (2002). Capillary leakage syndrome: a case report and a review.. PubMed. 34(10). 361–4. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact